A simple blood test is being rolled out across the UK as part of a new study to detect early signs of dementia decades before it develops and help identify treatments.
Antibiotics, antivirals, vaccinations and anti-inflammatory medication are associated with reduced risk of dementia, according to new research that looked at health data from over 130 million individuals.
Cambridge researchers have cast doubt on whether new amyloid immunotherapy drugs will have the desired effect of significantly reducing the impact of Alzheimer’s disease.
Cambridge scientists have developed an artificially-intelligent tool capable of predicting in four cases out of five whether people with early signs of dementia will remain stable or develop Alzheimer’s disease.
Cambridge researchers are helping lead countrywide trials to identify accurate and quick blood tests that can diagnose dementia, in a bid to improve the UK’s shocking diagnosis rate.
Cambridge scientists may have discovered a new way in which fasting helps reduce inflammation – a potentially damaging side-effect of the body’s immune system that underlies a number of chronic diseases.
Researchers have created the world’s largest ancient human gene bank, and used it to map the historical spread of genes – and diseases – over time as populations migrated.
Researchers have developed a method to identify new targets for human disease, including neurodegenerative conditions such as Alzheimer’s disease.
Cambridge scientists have shown how the brain’s ability to clear out toxic proteins is impaired in Huntington’s disease and other forms of dementia – and how, in a study in mice, a repurposed HIV drug was able to restore this function, helping prevent this dangerous build-up and slowing progression of the disease.
Cambridge scientists have shown that it may be possible to spot signs of brain impairment in patients as early as nine years before they receive a diagnosis for one of a number of dementia-related diseases.
© 2025 University of Cambridge